Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma. The company is headquartered in New York, New York. Show More...
-
Website https://indaptusrx.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.34 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 2020-12 2021-12 TTM Earnings Per Share USD -0.66 -1.89 -1.89 Dividends USD Payout Ratio % * Shares Mil 5.0 4.0 4.0 Book Value Per Share * USD 4.61 4.35 Free Cash Flow Per Share * USD -1.07 Return on Assets % -201.61 -36.41 -36.41 Financial Leverage (Average) 1.13 1.13 Return on Equity % -43.26 -43.26 Return on Invested Capital % -43.04 -43.04 Interest Coverage Current Ratio 0.86 8.77 8.77 Quick Ratio 0.81 8.5 8.5 Debt/Equity